Bindwell is an AI pesticide discovery company that uses deep learning and neural networks to design safer and more effective agricultural products.
Subscribe to see Bindwell’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Bindwell is an agtech company headquartered in United States. Its most recent funding round, Pre-Seed, raised $6M in November 2025. Xcout tracks 2 named people at Bindwell, including Navvye Anand (Co-founder).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $6M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Bindwell's closest competitors — see the full list of competitors and alternatives →
Quercus Biosolutions is a biotechnology company headquartered in Saint Louis, Missouri, that uses generative artificial intelligence to develop biology-based crop protection solutions.
Seed-X is a biotechnology research company based in Israel that utilizes artificial intelligence to revolutionize seed improvement and agricultural quality analysis.
Biographica is an agricultural technology and biotechnology company that builds machine learning platforms and utilizes knowledge graphs to accelerate gene discovery and crop improvement. The company specializes in graph-based biological modeling to support the development of productive, sustainable, and climate-resilient food sources.
Biomakers, Inc., also associated with Biome Makers, develops advanced soil intelligence technology such as the BeCrop platform. The company utilizes artificial intelligence tools to analyze agricultural soil microbiome data.
AQEMIA is a French technology company that uses quantum-inspired algorithms and artificial intelligence for drug discovery. It develops therapeutic candidates and works with pharmaceutical and biotechnology companies to accelerate the design of new medicines.
Variational AI is a privately held biotechnology startup headquartered in Vancouver, British Columbia. Founded in 2019, the company focuses on drug discovery, utilizing artificial intelligence to identify novel drug-like small molecules. Recognized as an innovative AI enterprise in Canada, it develops advanced computational methods for pharmaceutical research.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.